Cochrane Abstracts
Biopsy versus resection for the management of low‐grade gliomas
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Biopsy Versus Resection for the Management of Low‐grade Gliomas." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431482/all/Biopsy_versus_resection_for_the_management_of_low‐grade_gliomas.
Biopsy versus resection for the management of low‐grade gliomas. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431482/all/Biopsy_versus_resection_for_the_management_of_low‐grade_gliomas. Accessed March 18, 2025.
Biopsy versus resection for the management of low‐grade gliomas. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431482/all/Biopsy_versus_resection_for_the_management_of_low‐grade_gliomas
Biopsy Versus Resection for the Management of Low‐grade Gliomas [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 18]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431482/all/Biopsy_versus_resection_for_the_management_of_low‐grade_gliomas.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Biopsy versus resection for the management of low‐grade gliomas
ID - 431482
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431482/all/Biopsy_versus_resection_for_the_management_of_low‐grade_gliomas
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
